Stay updated on Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a platform/version update without changing the displayed clinical study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:41:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor platform version update.
    Difference
    0.0%
    Check dated 2026-04-17T02:50:57.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; a maintenance update with no changes to study details or criteria.
    Difference
    0.0%
    Check dated 2026-03-19T06:07:46.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:34:04.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.4.2; the funding-lapse notice and the older Revision: v3.4.1 text were removed.
    Difference
    0.3%
    Check dated 2026-02-11T11:48:45.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a system-wide notice about potential data delays due to a lapse in government funding and updated operating status guidance, with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T06:22:28.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.